Repligen Corporation is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Repligenâs corporate headquarters are in Waltham, MA (USA), with additional administrative and manufacturing operations in Marlborough, MA; Bridgewater, NJ; Rancho Dominguez, CA; Lund, Sweden; Breda, The Netherlands and Ravensburg, Germany. Source
No articles found.
Interpace Diagnostics is focused on developing and commercializing molecular diagn...
Interpace Diagnostics is focused on developing ...
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical c...
Corbus Pharmaceuticals Holdings, Inc. is a Phas...
Autolus is a clinical-stage, biopharmaceutical company, focused on the development...
Autolus is a clinical-stage, biopharmaceutical ...
Coloplast develops products and services that make life easier for people with ver...
Coloplast develops products and services that m...
Novocure is a global oncology company working to extend survival in some of the mo...
Novocure is a global oncology company working t...
CytoDyn is a publicly traded late stage biotechnology company developing innovativ...
CytoDyn is a publicly traded late stage biotech...
Lenders will write $1.5T of home mortgages in 2017, and will have to evaluate ever...
Lenders will write $1.5T of home mortgages in 2...
BASF Corporation, headquartered in Florham Park, New Jersey, is the North American...
BASF Corporation, headquartered in Florham Park...
Join the National Investor Network and get the latest information with your interests in mind.